NEW YORK, Jan. 24, 2018 -- The Nasdaq Stock Market announced today that it will delist the common stock of Cumulus Media Inc. Cumulus Media Inc.’s stock was suspended on November 22, 2017 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of root9B Holdings, Inc. root9B Holdings, Inc.’s stock was suspended on November 15, 2017 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of TearLab Corporation. TearLab Corporation’s stock was suspended on November 09, 2017 and has not traded on Nasdaq since that time.
Nasdaq also announced that it will delist the common stock of Giga-tronics Incorporated. Giga-tronics Incorporated’s stock was suspended on October 30, 2017 and has not traded on Nasdaq since that time.
Finally, Nasdaq announced that it will delist the common stock and warrant of Rennova Health, Inc. Rennova Health, Inc.’s common stock and warrant were suspended on October 25, 2017 and have not traded on Nasdaq since that time.
Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delisting for each of these companies. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delistings and whether the companies’ securities are trading on another venue, please review the companies’ public filings or contact the company directly.
For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: http://www.cchwallstreet.com/NasdaqTools/bookmark.asp?id=nasdaq-rule_5800&manual=/nasdaq/main/nasdaq-equityrules/.
-NDAQO-


Anta Sports Expands Global Footprint With Strategic Puma Stake
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Instagram Outage Disrupts Thousands of U.S. Users
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



